Neboglamine
guinea pig
The Dose Guy’s verdictOct 27, 20263 sources
Neboglamine is a legitimate drug-company molecule with a sensible mechanism, and nobody has ever shown it does anything in a human. Rottapharm took it into early human work for schizophrenia and nothing from that program reached a journal; the cognition case is rats, mice, and brain slices. I’d skip it unless you’re signing up as the experiment. If you want a glutamate-side nootropic for memory and focus with people behind it, noopept is the grounded pick.
What it is
The NMDA receptor is one of the brain’s main switches for learning, and it only opens when two keys turn: glutamate, and a co-agonist like glycine. Neboglamine is a glutamic acid derivative that makes the glycine key work better, raising how hard the receptor responds to glycine rather than mimicking glycine itself. In rats it restored the frontal-cortex signaling that the dissociative PCP knocks out, which is why the pharma interest pointed at schizophrenia, where weak NMDA signaling is one of the leading theories.
On the nootropic shelf that puts it in the glutamate corner with sunifiram and TAK-653. Of the three, only TAK-653 has human data, and noopept has more real-world use than any of them. What you can buy is a research chemical, not anything Rottapharm made.
What the research shows
Zero published human data. What exists is a tidy mechanism story from the 1990s and one later rat paper:
Realistic protocols
I’m not building a protocol for a molecule with no published human dose. Whatever number sits on a research-chemical label is a guess, because Rottapharm never published what it gave people, and the community has no consensus dose either. That absence is the warning. If you run it anyway, start well below the label, buy from a seller that posts a third-party test for the batch, since a research chemical with no pharmaceutical source is only as good as that batch, take it alone so you can tell what it does, and keep it away from other glutamate-side compounds, since stacking NMDA boosters is the obvious way to overshoot. Stop at the first headache, agitation, or broken sleep. Go short and log everything. And notice the trade: noopept and semax have human use behind them, and neboglamine has a hunch.
Side effects
Nobody has published a single human side effect, so this is mechanism and class expectation:
